Ascentage Pharma Group International (HKG:6855) appointed Faiçal Miyara as chief business officer and Jim Ziegler as chief commercial officer.
Miyara will oversee the company's global business development, while Ziegler will lead commercialization of its products in the United States and other markets outside China, according to a Monday Hong Kong bourse filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.